Drug Kinetics – Products

In a significant stride towards advancing nanoparticle drug delivery manufacturing technology, German pharmatech company, leon-nanodrugs GmbH (LEON), proudly announces a pioneering technical evaluation by CMAC, University of Strathclyde.

Fast-track your ADC journey with our comprehensive suite of high-quality materials for every stage of Antibody-Drug Conjugates development.

Growth of suppository manufacturing capabilities addresses increasing market demand to meet the needs
of geriatric and pediatric patients, and women’s health.

Semeta™ offers high sensitivity and superior precision for the prediction of Phase I and II metabolic routes, sites, products and liabilities in early drug discovery.

Strategic partnership harnesses respective organ-specific expertise to provide complete human-derived Organ-on-a-Chip solution for more accurate in vitro ADME predictions.

Novel GHz-class NMR systems are enabling unprecedented life science and materials research in functional structural biology, drug discovery, metabolomics and cleantech
research.

Innovative product enables medicinal chemists to access and integrate AI to boost productivity and creativity, to accelerate therapeutic drug discovery.

This technical note highlights a highly-sensitive on-demand workflow for quantifying peptides using accurate mass spectrometry (MS) approaches.

Peer-reviewed study published in Xenobiotica describes an innovative new method that predicts the routes and products of Phase I and II metabolism with high sensitivity and greater precision than other approaches.

This technical note highlights the latest mass spectrometry solutions and analysis software for the accurate quantitation of corticosteroids in human plasma.